Elixinol Wellness Limited
ELLXF
$0.012
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 125.15% | 125.74% | 19.94% | 21.92% | -18.39% |
| Total Depreciation and Amortization | 51.61% | 55.23% | 100.57% | 95.79% | 75.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 167.10% | 168.56% | -97.10% | -97.18% | -299.27% |
| Change in Net Operating Assets | -256.84% | -260.52% | -- | -- | 983.28% |
| Cash from Operations | 38.25% | 36.81% | -244.61% | -236.18% | 24.56% |
| Capital Expenditure | -36.11% | -38.89% | -4,833.33% | -4,833.33% | -125.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -86.77% |
| Cash Acquisitions | -345.21% | -350.87% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 100.00% | 334.69% | 328.96% | 73.86% |
| Cash from Investing | -433.00% | -446.31% | 143.48% | 142.40% | 90.17% |
| Total Debt Issued | 187.00% | 187.00% | -- | -- | -- |
| Total Debt Repaid | -120.00% | -120.00% | 49.85% | 49.85% | -7.63% |
| Issuance of Common Stock | -- | -- | 40.62% | 40.62% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -98.49% | -98.49% | -- |
| Cash from Financing | 1,485.16% | 1,519.94% | 49.99% | 46.29% | 74.32% |
| Foreign Exchange rate Adjustments | -43.75% | -43.75% | -107.87% | -107.69% | -114.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.63% | 78.13% | 378.76% | 366.83% | 43.13% |